- Home
- TKLF vs PRTG Comparison
TKLF vs PRTG Comparison
Compare TKLF & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- PRTG
- Stock Information
- Founded
- TKLF 2006
- PRTG 1973
- Country
- TKLF Japan
- PRTG British Virgin Islands
- Employees
- TKLF N/A
- PRTG N/A
- Industry
- TKLF Other Specialty Stores
- PRTG Oil & Gas Production
- Sector
- TKLF Consumer Discretionary
- PRTG Energy
- Exchange
- TKLF Nasdaq
- PRTG Nasdaq
- Market Cap
- TKLF 16.0M
- PRTG 17.7M
- IPO Year
- TKLF 2022
- PRTG N/A
- Fundamental
- Price
- TKLF $3.56
- PRTG $5.69
- Analyst Decision
- TKLF
- PRTG
- Analyst Count
- TKLF 0
- PRTG 0
- Target Price
- TKLF N/A
- PRTG N/A
- AVG Volume (30 Days)
- TKLF 10.6K
- PRTG 234.2K
- Earning Date
- TKLF 07-15-2025
- PRTG 08-26-2025
- Dividend Yield
- TKLF N/A
- PRTG N/A
- EPS Growth
- TKLF N/A
- PRTG N/A
- EPS
- TKLF 1.70
- PRTG N/A
- Revenue
- TKLF $219,520,631.00
- PRTG N/A
- Revenue This Year
- TKLF N/A
- PRTG N/A
- Revenue Next Year
- TKLF N/A
- PRTG N/A
- P/E Ratio
- TKLF $2.18
- PRTG N/A
- Revenue Growth
- TKLF 32.02
- PRTG N/A
- 52 Week Low
- TKLF $2.20
- PRTG $2.10
- 52 Week High
- TKLF $8.53
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- TKLF 51.46
- PRTG 39.99
- Support Level
- TKLF $3.20
- PRTG $5.24
- Resistance Level
- TKLF $3.85
- PRTG $6.84
- Average True Range (ATR)
- TKLF 0.20
- PRTG 0.76
- MACD
- TKLF -0.02
- PRTG -0.09
- Stochastic Oscillator
- TKLF 60.93
- PRTG 18.10
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.